Canaccord Genuity Starts ASP Isotopes Inc. (ASPI) at Buy

Canaccord Genuity analyst George Gianarikas initiates coverage on ASP Isotopes Inc. (NASDAQ: ASPI) with a Buy rating and a price target of $4.50.

The analyst comments "Upstart enricher. Hidden in the depths of South Africa’s sophisticated yet discreet nuclear technology industry, ASP holds significant promise. The upstart could help the West counter Russia’s dominance of the uranium supply chain. It could perhaps also lower the cost of enrichment in a dramatic fashion, particularly for HALEU (high assay low-enriched uranium), through its laser excitation enrichment technology. And, HALEU is the fuel of choice for the majority of next-generation nuclear reactor designs. Not to mention, ASP’s enrichment technology could yield several isotopes that may well advance the market for nuclear medicine and accelerate the adoption of advanced semiconductor technologies."

For an analyst ratings summary and ratings history on ASP Isotopes Inc. click here. For more ratings news on ASP Isotopes Inc. click here.

Shares of ASP Isotopes Inc. closed at $3.01 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Critical One Energy closes second tranche of flow-through placement
• Aurora Spine settles patent dispute, secures $600K insider loan